Our data corroborates the findings of a recent study that showed that elevated phosphorylation of JNK in ovarian cancer was significantly reversed by pretreatment with N-acetylcysteine (Zhang et al., 2022). The gene discussed is MAPK8; the disease is ovarian cancer.